Literature DB >> 15493187

Primary fallopian tube adenocarcinoma: preoperative diagnosis, treatment and follow-up.

M Varras1, Ch Akrivis, A Bellou, V D Malamou-Mitsi, N Antoniou, C Tolis, E Salamalekis.   

Abstract

Preoperative diagnosis of fallopian tube carcinoma is difficult due to the rarity and silent course of this neoplasm. We present herein the case of a 58-year-old woman with primary fallopian tube carcinoma that was diagnosed preoperatively on the basis of a positive for adenocarcinoma Papanicolaou vaginal smear, repeated episodes of vaginal bleeding, negative endocervical and endometrial curettage, characteristic features on ultrasonography and elevated CA-125 levels. The patient was treated by total abdominal hysterectomy, bilateral salpigno-oophorectomy and omentectomy. Pathologic confirmation of primary serous papillary adenocarcinoma of the left fallopian tube was made. Peritoneal washings were positive for malignancy. FIGO stage was considered as IIIb and the patient received six courses of combined carboplatin-taxol chemotherapy. At two years from onset of therapy the patient underwent a modified radical mastectomy and lymphadenectomy because of primary carcinoma of the right breast. The patient was started on tamoxifen therapy, which she is still taking. At 60 months after initial surgery, the patient is alive and well. In conclusion, our study suggests an association between fallopian tube carcinoma and breast cancer and a good response of the patient to platinum-based chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493187

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  Primary carcinoma of the fallopian tubes: Analysis of sixteen patients.

Authors:  Meryem Eken; Osman Temizkan; Ecmel Işık Kaygusuz; Dilşad Herkiloğlu; Ebru Çöğendez; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

2.  Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.

Authors:  Ying Ma; Wei Duan
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.